Shanghai Henlius Biotech, Inc. Financials

Market Capitalization HK$10.49 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	14.30
Forward PE	12.87
Price to Sales TTM	HK$1.86
Price to Book MRQ	HK$4.07
Enterprise to Revenue	2.46
Enterprise to EBITDA	12.77

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	12.27%
Operating Margin	16.32%
Return on Assets TTM	5.09%
Return on Equity TTM	30.99%

Income Statement

Revenue TTM	HK$5,991,339,150
Revenue per Share TTM	HK$10.38
Quarterly Revenue Growth	9.80%
Gross Profit TTM	HK$4,387,549,978
EBITDA	HK$1,069,630,000
Net Income to Common TTM	HK$735,397,282
Diluted EPS TTM	HK$1.35
Quarterly Earnings Growth YoY	61.00%

Balance Sheet

Total Cash MRQ	HK$706,891,271
Total Cash per Share MRQ	HK$1.22
Total Debt MRQ	HK$
Total Debt to Equity MRQ	157.24
Current Ratio MRQ	0.49
Book Value per Share MRQ	HK$4.74

Cash Flow

Operating Cash Flow TTM	HK$1,026,845,498
Levered Free Cash Flow TTM	HK$-146,955,858

2696 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	163,428,992
Float Shares	68,284,693
Avg 10 Volume	1,139,433
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.32%
% Held by Institutions	34.49%

Stock Price Summary

Beta	0.83
Fifty Two Week Low	HK$12.20
Fifty Two Week High	HK$23.95
Fifty Two Week Change	10.81%
Day 50 MA	HK$22.09
Day 200 MA	HK$20.91

Dividends and Splits

Forward Annual Dividend Rate	HK$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	HK$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date